Latest Herpes Zoster (Shingles) news
FDA Approves Prefilled Syringe Presentation for Shingles Vaccine
posted July 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Live Zoster Vaccination Linked to Lower Risk for Cardiovascular Events
posted May 8th
by modernClinician Editorial Team
by modernClinician Editorial Team
Zoster Vaccine Has Dementia-Preventing or Delaying Effect
posted April 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis 
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA 
Risk for Dementia Reduced With Receipt of Herpes Zoster Vaccine 
Shingles Vaccination May Promote Healthy Aging Related Articles
Two-Dose Recombinant Zoster Vaccine Effective in Older Adults, Regardless of Prior Vaccination 
Guidelines Issued for Vaccination as Part of Cardiovascular Care 
Two Doses of Zoster Vaccine Reduce Risk for Herpes Zoster Ophthalmicus 
Herpes Zoster Linked to Increased Long-Term Risk for Cognitive Decline Monthly Specialist Briefings
Stay Connected
